Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Yvonne, Saenger"'
Autor:
Lei Zheng, Jun Gong, John Powderly, Tanios Bekaii-Saab, Angela Alistar, Siqing Fu, Nashat Gabrail, Dae Won Kim, Yvonne Saenger, Olatunji Alese, Apollina Goel, Nataliya Uboha, Laura Agensky, Matteo Levisetti, Steven Margossian, Steve Quayle, J Eva Selfridge, Jorge Chaves, Jin Zhaohui
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/a058b50273b34e2ea776baa2cea44b42
Autor:
Jared M. Newton, Aurelie Hanoteau, Hsuan-Chen Liu, Angelina Gaspero, Falguni Parikh, Robyn D. Gartrell-Corrado, Thomas D. Hart, Damya Laoui, Jo A. Van Ginderachter, Neeraja Dharmaraj, William C. Spanos, Yvonne Saenger, Simon Young, Andrew G. Sikora
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-21 (2019)
Abstract Background Immune checkpoint inhibitors (ICIs) for solid tumors, including those targeting programmed cell death 1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), have shown impressive clinical efficacy, however, most patien
Externí odkaz:
https://doaj.org/article/5865ba33af83434c8d59aa844ab92960
Publikováno v:
World Journal of Meta-Analysis. 11:47-54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60c425ab4575e6a7e238372ea815a7b4
https://doi.org/10.13105/wjma.v11.i2.47
https://doi.org/10.13105/wjma.v11.i2.47
Autor:
Raul Rabadan, Robyn Gartrell, Yvonne Saenger, Benjamin Fullerton, Thomas Enzler, Pan Kim, Ladan Fazlollahi, Andrew Chen, Subha Perni, Stuart Weisberg, Emanuelle Rizk, Eun Jeong Oh, Xinzheng Guo, Codruta Chiuzan, Donna Farber, Helen Remotti, David Horowitz
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/3deb9e72fe3941deb4e7d44f043373aa
Autor:
Richard Carvajal, Yvonne Saenger, Matthew Ingham, Shaheer Khan, Diana McDonnell, Shana M Coley, Geoffrey Dube, Faramarz H Samie, Larisa J Geskin, Daniel Brouder
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Immune checkpoint blockade has emerged as a highly effective treatment for patients with metastatic melanoma and cutaneous squamous cell carcinoma. Nivolumab blocks the interactions between programmed cell death protein 1 and programmed de
Externí odkaz:
https://doaj.org/article/74a504e619b84516918d3cb0e557cb8f
Autor:
Douglas K. Marks, Robyn D. Gartrell, Margueritta El Asmar, Shuobo Boboila, Thomas Hart, Yan Lu, Qingfei Pan, Jiyang Yu, Hanina Hibshoosh, Hua Guo, Eleni Andreopoulou, Lisa Wiechmann, Katherine Crew, Joseph Sparano, Dawn Hershman, Eileen Connolly, Yvonne Saenger, Kevin Kalinsky
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: The PI3K/Akt/mTOR pathway in part impacts tumorigenesis through modulation of host immune activity. To assess the effects of Akt inhibition on the tumor micro-environment (TME), we analyzed tumor tissue from patients with operable hormone
Externí odkaz:
https://doaj.org/article/161752bec1d44d66a615bab9381ecca5
Autor:
Stuart P. Weisberg, Dustin J. Carpenter, Michael Chait, Pranay Dogra, Robyn D. Gartrell-Corrado, Andrew X. Chen, Sean Campbell, Wei Liu, Pooja Saraf, Mark E. Snyder, Masaru Kubota, Nichole M. Danzl, Beth A. Schrope, Raul Rabadan, Yvonne Saenger, Xiaojuan Chen, Donna L. Farber
Publikováno v:
Cell Reports, Vol 29, Iss 12, Pp 3916-3932.e5 (2019)
Summary: Non-recirculating tissue-resident memory T cells (TRMs) are the predominant T cell subset in diverse tissue sites, where they mediate protective immune responses in situ. Here, we reveal a role for TRM in maintaining immune homeostasis in th
Externí odkaz:
https://doaj.org/article/917d7b8fbddc49f39b3fe484a75b167b
Autor:
Carl Morrison, Sarabjot Pabla, Jeffrey M. Conroy, Mary K. Nesline, Sean T. Glenn, Devin Dressman, Antonios Papanicolau-Sengos, Blake Burgher, Jonathan Andreas, Vincent Giamo, Moachun Qin, Yirong Wang, Felicia L. Lenzo, Angela Omilian, Wiam Bshara, Matthew Zibelman, Pooja Ghatalia, Konstantin Dragnev, Keisuke Shirai, Katherine G. Madden, Laura J. Tafe, Neel Shah, Deepa Kasuganti, Luis de la Cruz-Merino, Isabel Araujo, Yvonne Saenger, Margaret Bogardus, Miguel Villalona-Calero, Zuanel Diaz, Roger Day, Marcia Eisenberg, Steven M. Anderson, Igor Puzanov, Lorenzo Galluzzi, Mark Gardner, Marc S. Ernstoff
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-12 (2018)
Abstract Background Immune checkpoint inhibitors (ICIs) have changed the clinical management of melanoma. However, not all patients respond, and current biomarkers including PD-L1 and mutational burden show incomplete predictive performance. The clin
Externí odkaz:
https://doaj.org/article/956c5246c411433fb1a686b13fb6565c
Autor:
Yvonne Saenger, Miriam Merad, Nina Bhardwaj, Jedd Wolchok, Andrew G. Sikora, Sebastian Bernardo, Padmini Jayaraman, Marylene Leboeuf, Arthur Mortha, Daigo Hashimoto, Ellen H. de Moll, Yichun Fu, Michael Pan, Marina Moskalenko
Supplemental Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c50a5244a1a13211302fd0920b6d6a2
https://doi.org/10.1158/2326-6066.22538846.v1
https://doi.org/10.1158/2326-6066.22538846.v1
Autor:
Yvonne Saenger, Miriam Merad, Nina Bhardwaj, Jedd Wolchok, Andrew G. Sikora, Sebastian Bernardo, Padmini Jayaraman, Marylene Leboeuf, Arthur Mortha, Daigo Hashimoto, Ellen H. de Moll, Yichun Fu, Michael Pan, Marina Moskalenko
Supplemental Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f88134a793ff524abda8ded0c3090eb
https://doi.org/10.1158/2326-6066.22538864.v1
https://doi.org/10.1158/2326-6066.22538864.v1